{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:10:42Z","timestamp":1780405842633,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["LH2022H013"],"award-info":[{"award-number":["LH2022H013"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118395","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:09:13Z","timestamp":1758132553000},"page":"118395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of 4-azaindoles derivatives: targeting the cardiac troponin I-interacting kinase (TNNI3K)"],"prefix":"10.1016","volume":"131","author":[{"given":"Ke","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118395_bb0005","doi-asserted-by":"crossref","unstructured":"Lam C.S.P., Yancy C. Universal Definition and Classification of Heart Failure: Is It universal? Does It Define Heart Failure? J Card Fail. 2021;27(5):509-511.","DOI":"10.1016\/j.cardfail.2021.03.003"},{"issue":"17","key":"10.1016\/j.bmc.2025.118395_bb0010","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"48","key":"10.1016\/j.bmc.2025.118395_bb0015","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure published correction appears","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.bmc.2025.118395_bb0020","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1253\/circj.CJ-14-0543","article-title":"Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease","volume":"78","author":"Lal","year":"2014","journal-title":"Circ J"},{"issue":"9","key":"10.1016\/j.bmc.2025.118395_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000647","article-title":"Tnni3k modifies disease progression in murine models of cardiomyopathy","volume":"5","author":"Wheeler","year":"2009","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.bmc.2025.118395_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000456400","article-title":"Overexpression of cardiac-specific kinase TNNI3K promotes mouse embryonic stem cells differentiation into cardiomyocytes","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.bmc.2025.118395_bb0035","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.RES.0000267744.92677.7f","article-title":"The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23\/24 phosphorylation","volume":"100","author":"Biesiadecki","year":"2007","journal-title":"Circ Res"},{"issue":"6716","key":"10.1016\/j.bmc.2025.118395_bb0040","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.adi8146","article-title":"Genetic excision of the regulatory cardiac troponin I extension in high-heart rate mammal clades","volume":"385","author":"Joyce","year":"2024","journal-title":"Science"},{"issue":"207","key":"10.1016\/j.bmc.2025.118395_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006479","article-title":"Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, inJury, and adverse remodeling in the ischemic heart","volume":"5","author":"Vagnozzi","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.bmc.2025.118395_bb0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/CIRCRESAHA.113.303238","article-title":"Inhibition of the cardiomyocyte-specific troponin I-interacting kinase limits oxidative stress, inJury, and adverse remodeling due to ischemic heart disease","volume":"114","author":"Abraham","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.bmc.2025.118395_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2012.10.004","article-title":"Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction","volume":"54","author":"Tang","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.bmc.2025.118395_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2015.03.008","article-title":"TNNI3K in cardiovascular disease and prospects for therapy","volume":"82","author":"Milano","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"18","key":"10.1016\/j.bmc.2025.118395_bb0065","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1021\/acs.jmedchem.5b00931","article-title":"Identification of purines and 7-Deazapurines as potent and selective type I inhibitors of troponin I-interacting kinase (TNNI3K)","volume":"58","author":"Lawhorn","year":"2015","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.bmc.2025.118395_bb0070","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1016\/j.bmcl.2016.05.033","article-title":"GSK114: a selective inhibitor for elucidating the biological role of TNNI3K","volume":"26","author":"Lawhorn","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.bmc.2025.118395_bb0075","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/acs.jmedchem.8b00125","article-title":"4,6-Diaminopyrimidines as highly preferred troponin I-interacting kinase (TNNI3K) inhibitors","volume":"61","author":"Philp","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118395_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112314","article-title":"Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction inJury","volume":"197","author":"Pang","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"21","key":"10.1016\/j.bmc.2025.118395_bb0085","doi-asserted-by":"crossref","first-page":"15651","DOI":"10.1021\/acs.jmedchem.1c00700","article-title":"Identification of Diarylurea inhibitors of the cardiac-specific kinase TNNI3K by designing selectivity against VEGFR2, p38\u03b1, and B-Raf","volume":"64","author":"Patterson","year":"2021","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118395_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1681.2011.05499.x","article-title":"Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy","volume":"38","author":"Wang","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.bmc.2025.118395_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/1414-431X20122515","article-title":"TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I","volume":"46","author":"Wang","year":"2013","journal-title":"Braz J Med Biol Res"},{"issue":"49","key":"10.1016\/j.bmc.2025.118395_bb0100","doi-asserted-by":"crossref","first-page":"19778","DOI":"10.1073\/pnas.1305427110","article-title":"Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms","volume":"110","author":"Vandeput","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bmc.2025.118395_bb0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13054-022-04165-z","article-title":"Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS\u00ae in a single center","volume":"26","author":"Monet","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.bmc.2025.118395_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155464","article-title":"Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT\/NF-\u03baB pathway","volume":"128","author":"Tuo","year":"2024","journal-title":"Phytomedicine"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:30:54Z","timestamp":1780403454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":22,"alternative-id":["S0968089625003360"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118395","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of 4-azaindoles derivatives: targeting the cardiac troponin I-interacting kinase (TNNI3K)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118395"}}